In this video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, noted the ongoing efforts to define long COVID and recent data suggesting physicians are not treating ...

One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.

The COVID-19 pandemic revealed how ill-prepared the world was to detect and respond to global health threats. With over 7·1 million lives lost,1 more than US$4·7 trillion in economic damage,2 profound ...

This month’s featured Healio Exclusive on the “evidence-based and ethically sound” definition of long COVID is particularly ...

The Trump administration’s dramatic strike at U.S. education research had been underway for months before Mark Warschauer learned that his own work would become a casualty. The renowned education ...

If we want to help fleets with their strategy, we have to get the day-to-day right, says Novuna's deputy managing director ...

At a glance, one could think of many ways to describe Paula Davis, but the phrase “empty shell” isn’t one of them. The 66-year-old mother of five from Salisbury Township is warm, energetic, determined ...

Despite afflicting more than 400 million people worldwide, the constellation of symptoms known as long COVID still confounds doctors and patients ...

Immunotherapy shows promise in reducing recurrence rates for high-risk skin cancer, despite mixed results in recent clinical ...

With a simple skin biopsy, researchers can learn about neurological conditions that may be associated with long COVID.